The cause of tumor-associated thrombocytosis remains unclear, however, the tumor-associated production of granulocyte-macrophage colony-stimulating factor or thrombopoietin (TPO) mediated by interleukin-6 is considered to be responsible for the increase in PLT count observed in cancer patients (29). This evidence concerns the gene CSF2 and cancer.